FI49302C - Menetelmä sepelvaltimoa laajentavien N6-bentsyyli-adenosiini-johdannai sten valmistamiseksi. - Google Patents

Menetelmä sepelvaltimoa laajentavien N6-bentsyyli-adenosiini-johdannai sten valmistamiseksi.

Info

Publication number
FI49302C
FI49302C FI673279A FI327967A FI49302C FI 49302 C FI49302 C FI 49302C FI 673279 A FI673279 A FI 673279A FI 327967 A FI327967 A FI 327967A FI 49302 C FI49302 C FI 49302C
Authority
FI
Finland
Prior art keywords
benzyl
preparation
adenosine derivatives
coronary dilating
dilating
Prior art date
Application number
FI673279A
Other languages
English (en)
Swedish (sv)
Other versions
FI49302B (fi
Inventor
Max Thiel
Kurt Stach
Werner Jahn
Wolfgang Schaumann
Karl Dietmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Application granted granted Critical
Publication of FI49302B publication Critical patent/FI49302B/fi
Publication of FI49302C publication Critical patent/FI49302C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
FI673279A 1966-12-09 1967-12-07 Menetelmä sepelvaltimoa laajentavien N6-bentsyyli-adenosiini-johdannai sten valmistamiseksi. FI49302C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEB0090219 1966-12-09
DEB0093416 1967-07-11

Publications (2)

Publication Number Publication Date
FI49302B FI49302B (fi) 1975-01-31
FI49302C true FI49302C (fi) 1975-05-12

Family

ID=25968244

Family Applications (1)

Application Number Title Priority Date Filing Date
FI673279A FI49302C (fi) 1966-12-09 1967-12-07 Menetelmä sepelvaltimoa laajentavien N6-bentsyyli-adenosiini-johdannai sten valmistamiseksi.

Country Status (8)

Country Link
US (1) US3506643A (fi)
AT (2) AT277475B (fi)
CH (2) CH509326A (fi)
FI (1) FI49302C (fi)
FR (2) FR1550512A (fi)
GB (1) GB1145789A (fi)
NL (1) NL130339C (fi)
SE (1) SE323383B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2007273A1 (de) * 1970-02-18 1971-08-26 Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof N(6) Aralkyl adenosin Derivate und Verfahren zur Herstellung derselben
DE2244328A1 (de) * 1972-09-09 1974-03-21 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
US4514405A (en) * 1981-09-17 1985-04-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Use of adenosine derivatives as anticonvulsants
US5284834A (en) * 1985-03-29 1994-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same
JPS63208525A (ja) * 1987-02-25 1988-08-30 Kikkoman Corp 心不全治療剤
AU4772493A (en) * 1992-07-15 1994-02-14 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Sulfo-derivatives of adenosine
US20030187261A1 (en) * 2000-01-07 2003-10-02 Libor Havlicek Purine derivatives, process for their preparation and use thereof
CZ294538B6 (cs) * 2002-12-30 2005-01-12 Ústav Experimentální Botaniky Akademie Vědčeské Re Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
US20070161582A1 (en) * 2003-08-08 2007-07-12 Dusan Mijikovic Pharmaceutical compositions and methods for metabolic modulation
JP5677425B2 (ja) 2009-06-29 2015-02-25 インサイト・コーポレイションIncyte Corporation Pi3k阻害剤としてのピリミジノン
WO2011075643A1 (en) * 2009-12-18 2011-06-23 Incyte Corporation Substituted heteroaryl fused derivatives as pi3k inhibitors
US8680108B2 (en) * 2009-12-18 2014-03-25 Incyte Corporation Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
CA2796311A1 (en) 2010-04-14 2011-10-20 Incyte Corporation Fused derivatives as pi3k.delta. inhibitors
WO2011163195A1 (en) 2010-06-21 2011-12-29 Incyte Corporation Fused pyrrole derivatives as pi3k inhibitors
EP2655374B1 (en) 2010-12-20 2019-10-23 Incyte Holdings Corporation N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
WO2012125629A1 (en) 2011-03-14 2012-09-20 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
US9126948B2 (en) 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
KR102507287B1 (ko) 2011-09-02 2023-03-07 인사이트 홀딩스 코포레이션 Pi3k 억제제로서 헤테로시클릴아민
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
PE20180129A1 (es) 2015-02-27 2018-01-18 Incyte Corp Sales de inhibidor de pi3k y procesos de preparacion
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3014900A (en) * 1959-01-26 1961-12-26 Upjohn Co Process for the preparation of ketosidopurines

Also Published As

Publication number Publication date
NL130339C (fi) 1970-12-15
AT276640B (de) 1969-11-25
NL6716737A (fi) 1968-06-10
SE323383B (fi) 1970-05-04
FR7285M (fi) 1969-09-22
GB1145789A (en) 1969-03-19
AT277475B (de) 1969-12-29
CH491119A (de) 1970-05-31
US3506643A (en) 1970-04-14
CH509326A (de) 1971-06-30
FI49302B (fi) 1975-01-31
FR1550512A (fi) 1968-12-20

Similar Documents

Publication Publication Date Title
FI49302C (fi) Menetelmä sepelvaltimoa laajentavien N6-bentsyyli-adenosiini-johdannai sten valmistamiseksi.
FI48590C (fi) Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi.
FI49716C (fi) Menetelmä 2,4-diamino-5-bentsyyli-pyrimidiinien valmistamiseksi.
FI46067C (fi) Menetelmä digitoksigeniiniglykosidien valmistamiseksi.
FI49971C (fi) Menetelmä mikrobeja tuhoavien 2-nitrofurfurylideeni-indanonijohdannais ten valmistamiseksi.
FI50334C (fi) Menetelmä 1-hydroksi-2pyridonien valmistamiseksi.
FI47575C (fi) Analogiamenetelmä evomonosidi-johdannaisten valmistamiseksi.
FI52216C (fi) Menetelmä gamma-piperidinobutyrofenonijohdannaisten valmistamiseksi.
FI45551C (fi) Menetelmä terapeuttisesti käytettävän dehydroepiandrosteroniönantaatin valmistamiseksi.
FI47489C (fi) Menetelmä tulehduksia ehkäisevien 5-(1-aroyyli-3-indolyyli-metyyli)-te tratsolien valmistamiseksi.
FI50975C (fi) Menetelmä pyratsiiniamidi-johdannaisten valmistamiseksi.
FI47577C (fi) Tapa valmistaa sepelvaltimoita laajentavan vaikutuksen omaavia 2,4,7-t riamino-6-fenyyli-pteridiinejä.
FI46727C (fi) Menetelmä pyridatsolijohdannaisten valmistamiseksi.
FI47578C (fi) Tapa valmistaa sepelvaltimoita laajentavan vaikutuksen omaavia 2,4,7-t riamino-6-fenyyli-pteridiinejä.
FI47576C (fi) Menetelmä 2-alkyyliamino-5-fenyyli-3H-1,4-bentsodiatsepiini-4-oksidien valmistamiseksi.
FI48724C (fi) Menetelmä N-karbamoyylioksifenyylikarbamaattien valmistamiseksi.
FI48088C (fi) Menetelmä 5-fenyyli-1H-1,4-bentsodiatsepiini-johdannaisten valmistamis eksi
FI47763C (fi) Menetelmä uusien neriifoliini-johdannaisten valmistamiseksi.
FI49308C (fi) Menetelmä 6-aminopenisillaanihapon valmistamiseksi.
FI47350C (fi) Tapa valmistaa 17alfa-propadienyyli-steroideja.
FI52088C (fi) Menetelmä 3-(4-asyylioksialkyyli-1-piperatsinyyli)-karbonyylimetyyli-2 -bentsotiatsolinonijohdannaisten valmistamiseksi.
NL146811B (nl) Werkwijze ter bereiding van 5-benzylpyrimidinederivaten.
FI46384C (fi) Menetelmä lääkeaineina vaikuttavien adenosiinijohdannaisten valmistami seksi.
FI49304C (fi) Menetelmä sepelvaltimoa laajentavien nebulariini-johdannaisten valmist amiseksi.
FI49162C (fi) Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi.